In the lab: T cells artificially endowed with 2 cancer-seeking receptors aim to be an elite army of cancer killers
Despite high remission rates for patients treated with T cells that are supercharged in laboratories into elite cancer warriors, there is still a considerable population of patients who eventually relapse, their cancers invariably ...